Treatment of diabetes mellitus-induced erectile dysfunction using endothelial progenitor cells genetically modified with human telomerase reverse transcriptase

Treatment of diabetes mellitus-induced erectile dysfunction using endothelial progenitor cells genetically modified with human telomerase reverse transcriptase

The efficacy of treatments for diabetes mellitus-induced erectile dysfunction (DMED) is quite poor, and stem cell therapy is emerging as a useful method. In this study, we used endothelial progenitor cells (EPCs) overexpressing human telomerase reverse transcriptase (hTERT) for the treatment of DMED...

Full description

Bibliographic Details
Main Authors: Zhang, Yan, Chen, Zhi, Wang, Tao, Yang, Jun, Li, Rui, Wang, Shaogang, Liu, Jihong, Ye, Zhangqun
Format: Online
Language:English
Published: Impact Journals LLC 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129934/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129934/

Similar Items